Next Article in Journal
Congenital Zika Virus Infection Impairs Corpus Callosum Development
Next Article in Special Issue
First Molecular Detection and Epidemiological Analysis of Equine Influenza Virus in Two Regions of Colombia, 2020–2023
Previous Article in Journal
Characterization of the Cynomolgus Macaque Model of Marburg Virus Disease and Assessment of Timing for Therapeutic Treatment Testing
 
 
Systematic Review
Peer-Review Record

Systematic Review of Equine Influenza A Virus Vaccine Studies and Meta-Analysis of Vaccine Efficacy

Viruses 2023, 15(12), 2337; https://doi.org/10.3390/v15122337
by Sol Elliott, Olaolu T. Olufemi and Janet M. Daly *
Reviewer 1:
Reviewer 2: Anonymous
Viruses 2023, 15(12), 2337; https://doi.org/10.3390/v15122337
Submission received: 28 October 2023 / Revised: 21 November 2023 / Accepted: 23 November 2023 / Published: 28 November 2023
(This article belongs to the Special Issue Equine Influenza 2023)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

A major undertaking, with many difficulties in making a solid metanalysis. The authors present as thorough of an analysis as I believe possible. 

Author Response

Thank you for the recognition of the effort this review took!

Reviewer 2 Report

Comments and Suggestions for Authors

The reviewed manuscript presents a meta-analysis of vaccination studies concerning equine influenza vaccines. The manuscript is well-written and provides a useful overview of the details of published vaccine studies that were included based on clearly defined criteria. However, it is not clear why studies without a clearly stated control group (table 3, studies 6, 41, 42) were included in the analysis when the inclusion of an appropriate comparison group was one of the stated inclusion criteria. This should be addressed.

The authors conclude that inconsistent study design did not allow for comparison of the efficacy of different vaccines, but that there was evidence for overall vaccine efficacy in preventing viral shedding. In addition, the authors showed that commercially available vaccines can, in some circumstances, offer complete protection from infection. The stated conclusion that the study offers evidence for frequent vaccination in the field seems a bit less supported – as only few studies addressed this issue – but the presentation of data allows the reader to draw their own conclusions.

The data presentation in tables and figures is appropriate and easy to understand; however, the list of abbreviations in table 3 is not complete (e.g. LAV-ca is not explained, MVA is not explained). This should be corrected.

Author Response

Thank you for highlighting the couple of issues found with the manuscript. These have been addressed as outlined in our letter (attached).

Author Response File: Author Response.pdf

Back to TopTop